The annual ACR Review Course covered key topics on Saturday, including areas that should be more familiar to rheumatologists than they are. “Virtually every rheumatic entity has an optic occurrence,” said James T. Rosenbaum, MD, Edward E. Rosenbaum Professor of Inflammatory Diseases and Chair of…
Most rheumatologists do not screen patients for hypertension, lipids, and other cardiovascular risk factors even though patients with rheumatoid arthritis (RA) and other autoimmune diseases have an increased risk for cardiovascular disease. “Cardiovascular disease is like a shark circling just beneath the surface in rheumatologic…
With the cost of sequencing a whole genome dropping below even exponential expectation, precision medicine has already made an impact on rheumatology. The two-day ACR CRC: Precision Medicine in Rheumatic Diseases: Hopes & Challenges provided a comprehensive look at past, ongoing, and future research initiatives and…
A Sunday symposium will review emerging comparative effectiveness research in small molecule and biologic therapies for rheumatoid arthritis (RA), the role of imaging in the clinical care of RA, and how to address infection risk when using these medications. The symposium, Update in RA: Benefits…
As the number of local governments legalizing marijuana continues to grow, society must come to grips with the legal and ethical ramifications of these new laws. While some patients with rheumatological and other disorders already avail themselves of cannabinoids for modification of their disease and…
An ACR symposium on Monday will update attendees on some important issues in gout treatment, including the recent publication of the American College of Physicians (ACP) gout treatment guideline, recommended best practice strategies for optimal imaging in gout, and recent advances in asymptomatic hyperuricemia and…
Always a popular session, the annual Thieves’ Market: Show Me Your Best Cases features the presentation of a variety of fascinating, mysterious, and uncommon clinical rheumatology cases and the opportunity for attendees to compare their diagnostic and management strategies to those of the presenter as…
Amyloidosis, the relatively rare condition that presents in many different ways and is often difficult to diagnose, is caused by the extracellular accumulation of the body’s own proteins in an abnormal, insoluble fibrillar form. The amyloid fibril deposits disrupt the structure and the function of…
Lupus is never a simple disease, but it can be easy to overlook complicating factors that transform a straightforward presentation into something more complex and challenging. And few factors offer more potential for complexity and complication than fever and cytopenia. “Rheumatologists are often asked to…
A pair of sessions on Monday will offer attendees an update on new and evolving technologies that have the potential to help rheumatology health professionals manage and treat rheumatic disease and improve patient access to rheumatologic care. From 1:00 – 2:00 pm in Room 32…